Elaeagnus conferta Roxb. (Elaeaganaceae), is being used in traditional herbal medicines; as the fruits, leaves and roots of this plant have been explored for the treatment of different diseases such as diabetes, ulcer, pain, rheumatism, diarrhea, inflammation and pulmonary disorders and also possess high nutritional value. Various extracts i.e. methanol, chloroform and acetone of E. conferta seeds were prepared by cold maceration and subjected to qualitative phytochemical screening (flavonoids, alkaloids, terpenoids, saponins, tannins, steroids, quinons, proteins, cardiac glycosides, fatty acid, carbohydrates and proteins) using standard procedures. All the extracts were further screened for antibacterial activity by disc diffusion method. The three different extracts of seeds of E. conferta were found to contain various secondary metabolites like fatty acids and flavonoids and exhibited moderate to significant antibacterial activity against both Gram-positive and Gram-negative bacteria. The potency of methanolic extract at conc. i.e.100 µg/ml was found to be > 19 mm in all the strains of bacteria (Streptococcus pyogenes, Staphylococcus aureus, Pseudomonas aeruginosa and Escherichia coli) which is comparable to standard drug ciprofloxacin. The various extracts of E. conferta exhibited variable antimicrobial activity, hence may be a natural potentially effective antimicrobial agent. Therefore, the above findings are important to strive medicinal role of E. conferta in treatment of various diseases including microbial infection.